Bank Julius Baer & Co’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.7K | Buy |
12,500
+1,440
| +13% | +$9.07K | ﹤0.01% | 516 |
|
|
2025
Q1 | $80.1K | Buy |
+11,060
| New | +$80.1K | ﹤0.01% | 506 |
|
|
2022
Q1 | – | Sell |
-3,258
| Closed | -$466K | – | 730 |
|
|
2021
Q4 | $466K | Sell |
3,258
-4,142
| -56% | -$592K | ﹤0.01% | 429 |
|
|
2021
Q3 | $1.54M | Buy |
7,400
+4,409
| +147% | +$916K | 0.01% | 280 |
|
|
2021
Q2 | $635K | Buy |
2,991
+2,641
| +755% | +$561K | ﹤0.01% | 413 |
|
|
2021
Q1 | $64K | Sell |
350
-5,183
| -94% | -$948K | ﹤0.01% | 649 |
|
|
2020
Q4 | $617K | Buy |
5,533
+33
| +0.6% | +$3.68K | 0.01% | 423 |
|
|
2020
Q3 | $596K | Sell |
5,500
-1,869
| -25% | -$203K | 0.01% | 357 |
|
|
2020
Q2 | $617K | Sell |
7,369
-30,048
| -80% | -$2.52M | 0.01% | 332 |
|
|
2020
Q1 | $508K | Buy |
+37,417
| New | +$508K | 0.01% | 311 |
|